Literature DB >> 15767492

The evidence supporting the early treatment for type 1 retinopathy of prematurity needs further evaluation.

Edward Averbukh.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15767492     DOI： 10.1001/archopht.123.3.406-a

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  3 in total

1.  The further refinement of ROP treatment. commentary on the early treatment of retinopathy of prematurity study: structural findings at 2 years of age.

Authors:  Alistair R Fielder; Andrew R Wilkinson
Journal:  Br J Ophthalmol       Date:  2007-02       Impact factor: 4.638

2.  The Early Treatment for Retinopathy of Prematurity Clinical Trial: presentation by subgroups versus analysis within subgroups.

Authors:  R J Hardy; W V Good; V Dobson; E A Palmer; B Tung; D L Phelps; M J Shapiro; W A J van Heuven
Journal:  Br J Ophthalmol       Date:  2006-11       Impact factor: 4.638

3.  [Current therapeutic options in retinopathy of prematurity].

Authors:  T U Krohne; S Aisenbrey; F G Holz
Journal:  Ophthalmologe       Date:  2012-12       Impact factor: 1.059
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.